logo conference-reports

Conference Reports

Educational funding by logo MSD Oncology

JSMO 2019 - Can microbiome be a marker to predict the efficacy of programmed death-1 inhibitor in cancer patients?

Gut microbiome affects virtually all aspects of human health, and may influence efficacy of PD-1 based immunotherapy